Published in Stroke, a new study sheds light on a tool doctors might use to help them predict the recovery of stroke patients in the future.
CADASIL is one of the most common genetic causes of stroke and dementia. Currently, there is no treatment for CADASIL. In this study, human stem cells will be generated from a piece of skin donated by patients with CADASIL. From these stem cells, smooth muscle cells (SMCs) will be generated in a tissue culture dish in the lab.
A research project to find out if a ‘polypill’ can help reduce the chance that people who have had a stroke will have a heart attack or another stroke.
Thousands of stroke survivors with visual problems could improve their sight from the comfort of their own home using two new web-based therapies.
Made in collaboration with patients and staff, a goal-setting tool should be produced which is helpful to use on stroke rehabilitation units.
Up to 70% of stroke survivors complain of tiredness or fatigue, sometimes years after stroke. Unlike normal tiredness, post stroke fatigue does not always respond to rest. The cause of extreme tiredness is not known and there are no definitive treatments available.
Stroke survivors and healthcare professionals have identified psychological and cognitive (thinking and mood) problems after stroke as someof the most important areas where more research is needed. This Lectureship will investigate how common these issues are after stroke, how they change over time, and how these changes can be predicted.
Published in the journal Age and Ageing, a new systematic review of the current research suggests that anticoagulant drugs may have cognitive benefit for those with AF (atrial fibrillation).
New study suggests that task-specific reach-to-grasp training for arm and hand rehabilitation is feasible for stroke survivors to perform, and acceptable for them to do.
Stroke survivors and healthcare professionals have identified problems with thinking and mood after stroke as some of the most important issues faced after a stroke. This Lectureship aims to test treatments to help stroke survivors with their cognitive (thinking) difficulties.